Innovative Genetic Screening – A Healthier Future for Newborns

The first days of life are priceless!

With the Newborn Genetic Screening offered by Nadezhda Hospital, you can gain peace of mind and confidence about your baby’s health.

The screening identifies more than 200 genetic disorders that cannot be detected through standard newborn examinations performed in maternity hospitals.

It includes the analysis of 237 genes associated with the risk of developing more than 200 of the most common genetic disorders manifesting in early childhood. These conditions are linked to serious health complications that can often be prevented through timely treatment or significantly improved through early intervention.

Early detection means early prevention, timely treatment, and a healthier future for your child.

With Newborn Genetic Screening, you receive more than a test—you gain reassurance and the opportunity to prevent potential health problems before symptoms appear.

Give your baby the most valuable gift of all: the opportunity for a healthy start in life.

With Newborn Genetic Screening at Nadezhda Hospital, you can:

• Detect hidden genetic disorders at an early stage;
• Create opportunities for timely treatment and intervention;
• Gain peace of mind knowing that you have done everything possible for your child’s future.

Nadezhda Hospital offers this genetic test for newborns as part of its commitment to safeguarding health from the very first moments of life.

Because modern medicine is about prediction and prevention.

Across Europe, obtaining a diagnosis for a rare disease often takes four to five years from the onset of symptoms. Newborn Genetic Screening eliminates the need for lengthy diagnostic journeys involving multiple specialists by enabling an early diagnosis and, when necessary, treatment immediately after birth.

For many of the conditions included in the screening panel, early detection allows treatment to begin before irreversible damage occurs. In some disorders, such as galactosemia, early treatment can significantly reduce the severity of complications. In others, such as phenylketonuria (PKU) and vitamin B6-dependent epilepsy, early intervention may prevent symptoms from developing altogether.

In biotinidase deficiency, for example, babies are born appearing completely healthy but may soon develop severe neurological complications. Treatment is straightforward and highly effective when initiated promptly. Early identification allows preventive therapy to begin before symptoms occur, enabling normal development.

To the best of our current knowledge, Nadezhda Hospital is the only healthcare institution in Bulgaria offering this specific newborn genetic screening test.

You can find detailed information about the Newborn Genetic Screening Test in the Genetics Laboratory section of our website.